Skip to main content
. 2022 Dec 2;10(12):2434. doi: 10.3390/healthcare10122434

Table 3.

Efficiency of 3-month ALA supplementation on the recovery of LSIL-positive patients (odds ratio and 95% Cl intervals).

Placebo
n = 48
(Final Visit)
Treated
n = 41
(Final Visit)
Odds Ratio 95% Cl p
Recovery (n) 4 39 0.004662 0.0008091–0.02686 <0.0001
LSIL (n) 44 2

Results are expressed as number of participants (n). Tested by Fisher’s exact test.